Interstitial Pneumonitis in a Patient with Chronic Myeloid Leukemia

Interstitial Pneumonitis in a Patient with Chronic Myeloid Leukemia

Bibliographic Details
Main Authors:	Ahmet Emre Eşkazan, Ayşe Salihoğlu, Serdar Erturan, Teoman Soysal
Format:	Article
Language:	English
Published:	Galenos Publishing House 2013-12-01
Series:	Turkish Journal of Hematology
Subjects:	hronic myeloid leukemia imatinib interstitial pneumonitis adverse even
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-73555

Similar Items

Imatinib-Induced Interstitial Pneumonitis Successfully Switched to Nilotinib in a Patient with Prior History of Mycobacterium tuberculosis Infection
by: Zhuan - Bo Luo, et al.
Published: (2017-11-01)

A rare complication of imatinib mesylate therapy: drug-induced pneumonitis
by: Ol'ga Veniaminovna Stakhina, et al.
Published: (2010-02-01)

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
by: Mario Tiribelli, et al.
Published: (2019-08-01)

Imatinib-induced interstitial pneumonitis – a literature review and case report
by: Olga Hilda Orasan, et al.
Published: (2020-04-01)

ABL gene kinase domain mutation scanning by denaturing high performance liquid chromatography sequencing method
by: Yücel Erbilgin, et al.
Published: (2011-05-01)

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01)

Treatment dilemmas in patients with gastrointestinal stromal tumors (GIST) who experienced imatinib-induced pneumonitis: A case series
by: Deborah van de Wal, et al.
Published: (2024-03-01)

ABL gene kinase domain mutation scanning by denaturing high performance liquid chromatography sequencing method
by: Yücel Erbilgin, et al.
Published: (2011-06-01)

Chronic myeloid leukemia and ferritin levels
by: Kumar Saurabh, et al.
Published: (2017-01-01)

Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines
by: Esma Bilajac, et al.
Published: (2022-12-01)

EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA AND ITS ASSOCIATION WITH BASELINE WHITE BLOOD CELL COUNT AND SPLEEN SIZE
by: Abdul Ali Wajid, et al.
Published: (2018-10-01)

Case report: Interstitial pneumonitis after initiation of lamotrigine
by: Victoria Watzal, et al.
Published: (2023-07-01)

Single Center Study of Prescribing and Treatment Outcomes of Patients with Chronic Myeloid Leukemia
by: Ladan Nekoohesh, et al.
Published: (2020-01-01)

Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease
by: V.D. Villgran, et al.
Published: (2021-01-01)

Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: A Study from the International Registry of Childhood CML
by: Frédéric Millot, et al.
Published: (2021-08-01)

OUR EXPERIENCE WITH TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Mojca Modic, et al.
Published: (2004-12-01)

Evaluation of the Safety of Imatinib Mesylate in 200 Iraqi Patients with Chronic Myeloid Leukemia in the Chronic Phase: Single-Center Study
by: Bassam Francis Matti, et al.
Published: (2013-12-01)

Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis
by: Sicong Li, et al.
Published: (2022-11-01)

Chronic Myeloid Leukemia with Variant Chromosomal Translocations: Results of Treatment with Imatinib Mesylate
by: Rohan Bhise, et al.
Published: (2013-01-01)

Imatinib Mesylate Treatment in Chronic Myeloid Leukemia
by: Demet Çekdemir, et al.
Published: (2020-03-01)

A case of double leukemia: chronic myeloid leukemia intolerant to imatinib and chronic lymphocytic leukemia
by: Miriana Rocchi
Published: (2015-10-01)

Reacciones adversas del imatinib como droga de segunda línea en pacientes con leucemia mieloide crónica Adverse reactions to imatinib as second-line drug in patients with chronic myeloid leukemia
by: Onel M. Ávila Cabrera, et al.
Published: (2010-12-01)

Hodgkin Lymphoma in a Case of Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors
by: Smeeta GAJENDRA, et al.
Published: (2019-01-01)

Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia
by: Ekaterina Yu. Chelysheva, et al.
Published: (2022-08-01)

Long-term treatment outcome in chronic myeloid leukemia patients in accelerated phase treated with imatinib (glevec®)
by: L. A. Antipova, et al.
Published: (2022-11-01)

Palisaded and interstitial granulomatous dermatitis in a child with acute myeloid leukemia
by: Dhwanee Thakkar
Published: (2016-10-01)

Usual interstitial pneumopathy in a patient with hypersensitivity pneumonitis and microscopic polyangiitis. Case report
by: Ana Gabriela Pérez-Romero, et al.
Published: (2024-01-01)

Low-dose methotrexate-induced acute interstitial pneumonitis: Report of two cases from South India and review of literature
by: Ramya Iyyadurai, et al.
Published: (2016-01-01)

Parasitic infestation of lung: An unusual cause of interstitial pneumonitis
by: Parth Shah, et al.
Published: (2016-01-01)

Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature
by: Renata Ferrarotto, et al.
Published: (2011-12-01)

Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?
by: Olga Meltem Akay, et al.
Published: (2016-05-01)

Evaluation of visual evoked potential in chronic myeloid leukemias
by: Avishkar Agrawal, et al.
Published: (2023-01-01)

Relationship between Oxidative Stress and Imatinib Resistance in Model Chronic Myeloid Leukemia Cells
by: Sylwester Głowacki, et al.
Published: (2021-04-01)

Drug-Induced interstitial pneumonitis in a case of breast malignancy
by: Hemalatha Padmanathan, et al.
Published: (2022-01-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

OUR EXPERIENCE IN TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Marjana Glaser, et al.
Published: (2004-04-01)

Outcome of young adults with chronic myeloid leukemia treated with upfront imatinib: A single institutional experience
by: Govind K Babu, et al.
Published: (2015-01-01)

Comparison of effectiveness and safety of Iranian-made vs. Indian-made imatinib in treatment of chronic myeloid leukemia
by: Kamran Moshfeghi, et al.
Published: (2013-01-01)

Comparative study for the efficacy, safety and quality of life in patients of chronic myeloid leukemia treated with Imatinib or Hydroxyurea
by: Parveen Jain, et al.
Published: (2013-01-01)